Urinary exosomal microRNA profiling in type 2 diabetes patients taking dipeptidyl peptidase-4 inhibitor compared with sulfonylurea-Reference-Cited by-同舟云学术

Urinary exosomal microRNA profiling in type 2 diabetes patients taking dipeptidyl peptidase-4 inhibitor compared with sulfonylurea

Published:2021-09-30 Issue:3 Volume:40 Page:383-391
ISSN:2211-9140
Container-title:Kidney Research and Clinical Practice
language:en
Short-container-title:Kidney Res Clin Pract

Author:

Cho Nam-Jun^ORCID,Kim Dae-Yeon^ORCID,Kwon Soon Hyo^ORCID,Ha Tae Won^ORCID,Kim Hyun Kyu^ORCID,Lee Man Ryul^ORCID,Chun Sung Wan^ORCID,Park Samel^ORCID,Lee Eun-young^ORCID,Gil Hyo-Wook^ORCID

Funder

e Daewoong and Sonchunhyang University

Publisher

The Korean Society of Nephrology

Subject

Urology,Nephrology

Link

http://www.krcp-ksn.org/upload/pdf/j-krcp-21-015.pdf

Reference31 articles.

1. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025

2. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

3. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

4. Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease;World Journal of Diabetes;2024-01-15

2. Identification of urinary extracellular vesicles differentially expressed RNAs in diabetic nephropathy via whole-transcriptome integrated analysis;Computers in Biology and Medicine;2023-11

3. Exosome-Based Drug Delivery: Translation from Bench to Clinic;Pharmaceutics;2023-07-29

4. Weight Change Alters the Small RNA Profile of Urinary Extracellular Vesicles in Obesity;Obesity Facts;2022

5. MSCs-exosomes in regeneration medicine: Current evidence and future perspectives;BIOCELL;2022